Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00778011 · ClinicalTrials.gov registry record · Phase 4
Uncomplicated Nausea and Vomiting in the Emergency Department
A Phase 4 study, sponsored by WellSpan Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 137
- Enrollment target
NCT00778011 is a Phase 4 study that has completed, run by WellSpan Health. The registered enrollment target is 137 participants.
The verdict
NCT00778011, a Phase 4 study, has completed, sponsored by WellSpan Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 137 participants
- Enrollment target
Study Summary
Nausea and vomiting is a common complaint in the emergency department. Treatment is important for many reasons. In addition to patient comfort, there are adverse effects secondary to vomiting such as dehydration, metabolic alkalosis, Mallory-Weiss tears, and aspiration. Two mediations common used for nausea in ED patients include Ondanesetron and Metoclopramide.
Interventions
- DRUG Ondansetron
- DRUG Metoclopramide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2005-11 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00778011
The ClinicalTrials.gov registry entry for NCT00778011 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is WellSpan Health, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ondansetron is the first listed.
NCT00778011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00778011 about?
NCT00778011 is a clinical study titled "Uncomplicated Nausea and Vomiting in the Emergency Department". Nausea and vomiting is a common complaint in the emergency department. Treatment is important for many reasons. In addition to patient comfort, there are adverse effects secondary to vomiting such as dehydration, metabolic alkalosis, Mallory-Weiss tears, and aspiration. Two mediations common used fo...
What is the current status of trial NCT00778011?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 137 participants. The study started on 2005-11. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00778011?
The interventions under investigation include: Ondansetron (DRUG), Metoclopramide (DRUG).
Who is sponsoring clinical trial NCT00778011?
This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.